P49137 (MAPK2_HUMAN) Homo sapiens (Human)
MAP kinase-activated protein kinase 2 UniProtKBInterProSTRINGInteractive Modelling
400 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
30 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Ternary complex of P38 and MK2 with a P38 inhibitor |
Heteromer P47811; | 100.0 | 1×39G; | |||
| Phosphorylated p38 and MAPKAPK2 complex with inhibitor |
Heteromer Q16539; | 100.0 | 1×39G; | |||
| Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer |
Heteromer Q16539; | 100.0 | ||||
| Structure of p38alpha complex |
Heteromer P47811; | 100.0 | ||||
| Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer |
Heteromer Q16539; | 100 | ||||
| Binding site mapping of protein ligands | homo-12-mer | 100.0 | 12×P4O; | |||
| Crystal structure of MAPKAP Kinase-2 (MK2) in complex with non-selective inhibitor | homo-12-mer | 100.0 | 12×YRZ; | |||
| Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2) | homo-12-mer | 100.0 | 24×PDY; 1×SO4; | |||
| Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperaz… | homo-6-mer | 100.0 | 6×B97; 6×CL; 6×MW8; | |||
| Re-refinement of MAPKAP kinase-2/inhibitor complex 3fyj | homo-3-mer | 100.0 | 3×B97; 3×CL; 3×MLA; | |||
| Crystal structure of a benzthiophene lead bound to MAPKAP Kinase-2 (MK-2) | homo-3-mer | 100.0 | 3×B98; | |||
| Crystal structure of an optimzied benzothiophene inhibitor bound to MAPKAP Kinase-2 (MK-2) | homo-3-mer | 100.0 | 3×B97; | |||
| MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine | homo-3-mer | 100.0 | 3×MK2; | |||
| Crystal Structure of MAPKAP2 | monomer | 100.0 | 7×HG; | |||
| Crystal structure of a pyrrolopyridine inhibitor bound to MAPKAP Kinase-2 | monomer | 100.0 | 1×F10; | |||
| Crystal structure of MAPKAK kinase 2 (MK2) complexed with a spiroazetidine-tetracyclic ATP site inh… | monomer | 100 | 1×L8I; 1×MG; | |||
| Crystal structure of MAPKAP kinase 2 (MK2) complexed with a potent 3-aminopyrazole ATP site inhibit… | monomer | 100 | 1×MG; 1×LX9; | |||
| The Crystal Structure of MAPKAP kinase 2 domain from Biortus | monomer | 99.66 | ||||
| Crystal structure of MAPKAP kinase 2 (MK2) complexed with a tetracyclic ATP site inhibitor | monomer | 100 | 1×MG; 1×HGF; | |||
| MK2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-N-methylbenzo[b]thiop… | monomer | 100.0 | 1×MK3; | |||
| Structure of MK2 Complexed with Compound 76 | monomer | 100.0 | 1×B18; | |||
| Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization) | monomer | 100.0 | 1×P4O; | |||
| The Crystal Structure of MAPK2 from Biortus. | monomer | 100.0 | ||||
| Crystal structure of staurosporine bound to MAP KAP kinase 2 | monomer | 100.0 | 1×STU; | |||
| Protein kinase MK2 in complex with an inhibitor (crystal form-1, soaking) | monomer | 100.0 | 1×PO4; 1×P4O; | |||
| Crystal Structure of a Squarate Inhibitor bound to MAPKAP Kinase-2 | monomer | 100.0 | 1×793; | |||
| Crystal structure of ADP bound to MAP KAP kinase 2 | monomer | 100.0 | 1×ADP; | |||
| MK2 kinase bound to Compound 1 | monomer | 100.0 | 2×MLI; 1×P4O; | |||
| MK2 kinase bound to Compound 2 | monomer | 100.0 | 1×CD2; | |||
| MK2 kinase bound to Compound 5b | monomer | 100.0 | 1×05B; | |||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 1nxk.5.H | monomer | 0.79 | 1×STU; | 100.00 | ||
| 1kwp.2.A | monomer | 0.69 | 4×HG; | 100.00 | ||
| 2onl.1.B | monomer | 0.66 | 100.00 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 1nxk.5.H | monomer | 0.79 | 1×STU; | 99.72 | ||